AWM
ALZN icon

Activest Wealth Management’s Alzamend Neuro ALZN Stock Holding History

Activest Wealth Management’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$5 – 1148
2025
Q2 		$6 Hold
2
– – ﹤0.01% 1030
2025
Q1 		$19 Hold
2
– – ﹤0.01% 1017
2024
Q4 		$23 Hold
2
– – ﹤0.01% 831
2024
Q3 		$34 Hold
2
– – ﹤0.01% 542
2024
Q2 		$79 Buy
+2
New +$114 ﹤0.01% 500

Other funds holding ALZN

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Activest Wealth Management's ALZN Position: Q3 2025 in Review

Activest Wealth Management sold out of Alzamend Neuro (ALZN) in Q3 2025, closing a stake of 2 shares — an estimated $5 sold.

Activest Wealth Management first reported a position in ALZN in Q2 2024 and held it in 5 quarters. The position peaked at $79 in Q2 2024. 11 funds tracked by Wall St. Rank hold ALZN as of Q3 2025.

  • Activest Wealth Management reported no remaining Alzamend Neuro position as of Q3 2025 after selling out during the quarter.
  • Activest Wealth Management sold 2 Alzamend Neuro shares in Q3 2025, an estimated $5.
  • Activest Wealth Management first reported a position in Alzamend Neuro in Q2 2024 and held it in 5 quarters.
  • Activest Wealth Management's Alzamend Neuro position peaked at $79 in Q2 2024.
  • 11 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2025.

Based on Activest Wealth Management's 13F filing for Q3 2025, filed 3 Nov 2025.